Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ZIL2.DE
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 0.30 1.41 1.40
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 29.18 6.57 5.09
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.74 13.41 13.31
Cash 18.39 2.37 2.00
Capex 32.32 -0.36 -0.53
Free Cash Flow -83.35 -0.10 0.57
Revenue 5.98 7.34 6.93
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 10.11 0.24 0.22
Operating Margin -17.49 0.05 0.07
ROA -40.29 < 0.005 0.01
ROE -41.17 0.02 0.03
ROIC -80.71 0.01 0.07
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ZIL2.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ZIL2.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ZIL2.DE is permitted for members.